<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31796040</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1741-7015</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Dec</Month><Day>04</Day></PubDate></JournalIssue><Title>BMC medicine</Title><ISOAbbreviation>BMC Med</ISOAbbreviation></Journal><ArticleTitle>Causal association of type 2 diabetes with amyotrophic lateral sclerosis: new evidence from Mendelian randomization using GWAS summary statistics.</ArticleTitle><Pagination><StartPage>225</StartPage><MedlinePgn>225</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">225</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12916-019-1448-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Associations between type 2 diabetes (T2D) and amyotrophic lateral sclerosis (ALS) were discovered in observational studies in both European and East Asian populations. However, whether such associations are causal remains largely unknown.</AbstractText><AbstractText Label="METHODS">We employed a two-sample Mendelian randomization approach to evaluate the causal relationship of T2D with the risk of ALS in both European and East Asian populations. Our analysis was implemented using summary statistics obtained from large-scale genome-wide association studies with ~660,000 individuals for T2D and ~81,000 individuals for ALS in the European population, and ~191,000 individuals for T2D and ~4100 individuals for ALS in the East Asian population. The causal relationship between T2D and ALS in both populations was estimated using the inverse-variance-weighted methods and was further validated through extensive complementary and sensitivity analyses.</AbstractText><AbstractText Label="RESULTS">Using multiple instruments that were strongly associated with T2D, a negative association between T2D and ALS was identified in the European population with the odds ratio (OR) estimated to be 0.93 (95% CI 0.88-0.99, p&#x2009;=&#x2009;0.023), while a positive association between T2D and ALS was observed in the East Asian population with OR&#x2009;=&#x2009;1.28 (95% CI 0.99-1.62, p&#x2009;=&#x2009;0.058). These results were robust against instrument selection, various modeling misspecifications, and estimation biases, with the Egger regression and MR-PRESSO ruling out the possibility of horizontal pleiotropic effects of instruments. However, no causal association was found between T2D-related exposures (including glycemic traits) and ALS in the European population.</AbstractText><AbstractText Label="CONCLUSION">Our results provide new evidence supporting the causal neuroprotective role of T2D on ALS in the European population and provide empirically suggestive evidence of increasing risk of T2D on ALS in the East Asian population. Our results have an important implication on ALS pathology, paving ways for developing therapeutic strategies across multiple populations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Ping</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2710-3440</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China. zpstat@xzhmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Junnian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cancer Institute, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China. jnzheng@xzhmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Clinical Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221004, China. jnzheng@xzhmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China. jnzheng@xzhmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Michigan, Ann Arbor, MI, 48109, USA. xzhousph@umich.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, 48109, USA. xzhousph@umich.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HG009124</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med</MedlineTA><NlmUniqueID>101190723</NlmUniqueID><ISSNLinking>1741-7015</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057182" MajorTopicYN="N">Mendelian Randomization Analysis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">East Asian</Keyword><Keyword MajorTopicYN="N">European</Keyword><Keyword MajorTopicYN="N">Genome-wide association studies</Keyword><Keyword MajorTopicYN="N">Instrumental variable</Keyword><Keyword MajorTopicYN="N">Two-sample Mendelian randomization</Keyword><Keyword MajorTopicYN="N">Type 2 diabetes</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31796040</ArticleId><ArticleId IdType="pmc">PMC6892209</ArticleId><ArticleId IdType="doi">10.1186/s12916-019-1448-9</ArticleId><ArticleId IdType="pii">10.1186/s12916-019-1448-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Boum&#xe9;diene F, Logroscino G, Couratier P, Babron M-C, Leutenegger AL, Copetti M, Preux P-M, Beghi E. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46(1):57&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5407171</ArticleId><ArticleId IdType="pubmed">27185810</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, Traynor BG, Eurals C. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10(5&#x2013;6):310&#x2013;323. doi: 10.3109/17482960802566824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman M, Zinman L. The economic impact of amyotrophic lateral sclerosis: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2015;15(3):439&#x2013;450. doi: 10.1586/14737167.2015.1039941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14737167.2015.1039941</ArticleId><ArticleId IdType="pubmed">25924979</ArticleId></ArticleIdList></Reference><Reference><Citation>Larkindale J, Yang W, Hogan PF, Simon CJ, Zhang Y, Jain A, Habeeb-Louks EM, Kennedy A, Cwik VA. Cost of illness for neuromuscular diseases in the United States. Muscle Nerve. 2014;49(3):431&#x2013;438. doi: 10.1002/mus.23942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.23942</ArticleId><ArticleId IdType="pubmed">23836444</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur KC, Calvo A, Price TR, Geiger JT, Chi&#xf2; A, Traynor BJ. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun. 2016;7:12408. doi: 10.1038/ncomms12408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12408</ArticleId><ArticleId IdType="pmc">PMC4987527</ArticleId><ArticleId IdType="pubmed">27510634</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344(22):1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9(11):617&#x2013;628. doi: 10.1038/nrneurol.2013.203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.203</ArticleId><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U, Dori-Bachash M, Kleimeyer C, Moresi C, Harnik Y, Zur M, et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019;572(7770):474&#x2013;480. doi: 10.1038/s41586-019-1443-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1443-5</ArticleId><ArticleId IdType="pubmed">31330533</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollinger SK, Okosun IS, Mitchell CS. Antecedent disease and amyotrophic lateral sclerosis: what is protecting whom? Front Neurol. 2016;7:47. doi: 10.3389/fneur.2016.00047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2016.00047</ArticleId><ArticleId IdType="pmc">PMC4810157</ArticleId><ArticleId IdType="pubmed">27065942</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell CS, Hollinger SK, Goswami SD, Polak MA, Lee RH, Glass JD. Antecedent disease is less prevalent in amyotrophic lateral sclerosis. Neurodegener Dis. 2015;15(2):109&#x2013;113. doi: 10.1159/000369812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000369812</ArticleId><ArticleId IdType="pmc">PMC4417009</ArticleId><ArticleId IdType="pubmed">25720304</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid A, Salamone AR, Strutt AM, Murthy SB, Wheaton M, McDowell EJ, Simpson E, Appel SH, York MK, Schulz PE. ALS disease onset may occur later in patients with pre-morbid diabetes mellitus. Eur J Neurol. 2010;17(5):733&#x2013;739. doi: 10.1111/j.1468-1331.2009.02923.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02923.x</ArticleId><ArticleId IdType="pubmed">20074230</ArticleId></ArticleIdList></Reference><Reference><Citation>Armon C, Kurland LT, O'Brien PC, Mulder DW. Antecedent medical diseases in patients with amyotrophic lateral sclerosis. A population-based case-controlled study in Rochester, Minn, 1925 through 1987. Arch Neurol. 1991;48(3):283&#x2013;286. doi: 10.1001/archneur.1991.00530150051017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1991.00530150051017</ArticleId><ArticleId IdType="pubmed">2001186</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Ovidio F, d'Errico A, Carna P, Calvo A, Costa G, Chio A. The role of pre-morbid diabetes on developing amyotrophic lateral sclerosis. Eur J Neurol. 2018;25(1):164&#x2013;170. doi: 10.1111/ene.13465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13465</ArticleId><ArticleId IdType="pubmed">28921834</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser AE, Seelen M, Hulsbergen A, de Graaf J, van der Kooi AJ, Raaphorst J, Veldink JH, van den Berg LH. Exploring the fitness hypothesis in ALS: a population-based case-control study of parental cause of death and lifespan. J Neurol Neurosurg Psychiatry. 2017;88(7):550&#x2013;556. doi: 10.1136/jnnp-2016-315071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315071</ArticleId><ArticleId IdType="pubmed">28292782</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D, Kamel F, Bellocco R, Ye W, Fang F. Association between diabetes and amyotrophic lateral sclerosis in Sweden. Eur J Neurol. 2015;22(11):1436&#x2013;1442. doi: 10.1111/ene.12632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12632</ArticleId><ArticleId IdType="pmc">PMC4506907</ArticleId><ArticleId IdType="pubmed">25600257</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelen M, van Doormaal PTC, Visser AE, Huisman MHB, Roozekrans MHJ, de Jong SW, van der Kooi AJ, de Visser M, Voermans NC, Veldink JH, et al. Prior medical conditions and the risk of amyotrophic lateral sclerosis. J Neurol. 2014;261(10):1949&#x2013;1956. doi: 10.1007/s00415-014-7445-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-014-7445-1</ArticleId><ArticleId IdType="pubmed">25059395</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Goldacre R, Ramagopalan S, Talbot K, Goldacre MJ. Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology. 2013;81(14):1222&#x2013;1225. doi: 10.1212/WNL.0b013e3182a6cc13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182a6cc13</ArticleId><ArticleId IdType="pmc">PMC3795611</ArticleId><ArticleId IdType="pubmed">23946298</ArticleId></ArticleIdList></Reference><Reference><Citation>Kioumourtzoglou M-A, Rotem RS, Seals RM, Gredal O, Hansen J, Weisskopf MG. Diabetes mellitus, obesity, and diagnosis of amyotrophic lateral sclerosis: a population-based study. JAMA Neurol. 2015;72(8):905&#x2013;911. doi: 10.1001/jamaneurol.2015.0910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.0910</ArticleId><ArticleId IdType="pmc">PMC4975611</ArticleId><ArticleId IdType="pubmed">26030836</ArticleId></ArticleIdList></Reference><Reference><Citation>Moglia C, Calvo A, Canosa A, Bertuzzo D, Cugnasco P, Solero L, Grassano M, Bersano E, Cammarosano S, Manera U. Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(7&#x2013;8):590&#x2013;597. doi: 10.1080/21678421.2017.1336560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1336560</ArticleId><ArticleId IdType="pubmed">28616937</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;rner S, Kollewe K, Ilsemann J, M&#xfc;ller-Heine A, Dengler R, Krampfl K, Petri S. Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis. Eur J Neurol. 2012;20(4):647&#x2013;654. doi: 10.1111/ene.12015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12015</ArticleId><ArticleId IdType="pubmed">23094606</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Lu C-J, Chen R-C, Hou W-H, Li C-Y. Risk of amyotrophic lateral sclerosis in patients with diabetes: a nationwide population-based cohort study. J Epidemiol. 2015;25(6):445&#x2013;451. doi: 10.2188/jea.JE20140176.</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.JE20140176</ArticleId><ArticleId IdType="pmc">PMC4444499</ArticleId><ArticleId IdType="pubmed">25947580</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne T, De Bock K, Van Den Bosch L. Energy metabolism in ALS: an underappreciated opportunity? Acta Neuropathol (Berl) 2018;135(4):489&#x2013;509. doi: 10.1007/s00401-018-1835-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1835-x</ArticleId><ArticleId IdType="pmc">PMC5978930</ArticleId><ArticleId IdType="pubmed">29549424</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Pradat P-F, Ludolph AC, Loeffler J-P. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10(1):75&#x2013;82. doi: 10.1016/S1474-4422(10)70224-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70224-6</ArticleId><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Harno K, Rissanen A, Palo J. Glucose tolerance in amyotrophic lateral sclerosis. Acta Neurol Scand. 1984;70(6):451&#x2013;455. doi: 10.1111/j.1600-0404.1984.tb00851.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1984.tb00851.x</ArticleId><ArticleId IdType="pubmed">6516795</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat PF, Bruneteau G, Gordon PH, Dupuis L, Bonnefont-Rousselot D, Simon D, Salachas F, Corcia P, Frochot V, Lacorte J-M, Jardel C, et al. Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11(1&#x2013;2):166&#x2013;171. doi: 10.3109/17482960902822960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902822960</ArticleId><ArticleId IdType="pubmed">20184518</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G. Are diabetes and amyotrophic lateral sclerosis related? Nat Rev Neurol. 2015;11:488&#x2013;490. doi: 10.1038/nrneurol.2015.145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2015.145</ArticleId><ArticleId IdType="pubmed">26281962</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid A, Brown JA, Schulz PE. Diabetes mellitus in amyotrophic lateral sclerosis: Dr Jekyll or Mr Hyde? Eur J Neurol. 2015;22(11):1419&#x2013;1420. doi: 10.1111/ene.12660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12660</ArticleId><ArticleId IdType="pubmed">25597340</ArticleId></ArticleIdList></Reference><Reference><Citation>Lekoubou A, Matsha TE, Sobngwi E, Kengne AP. Effects of diabetes mellitus on amyotrophic lateral sclerosis: a systematic review. BMC Res Notes. 2014;7:171. doi: 10.1186/1756-0500-7-171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-0500-7-171</ArticleId><ArticleId IdType="pmc">PMC3987838</ArticleId><ArticleId IdType="pubmed">24661645</ArticleId></ArticleIdList></Reference><Reference><Citation>Paternoster L, Tilling K, Davey Smith G. Genetic epidemiology and Mendelian randomization for informing disease therapeutics: conceptual and methodological challenges. PLoS Genet. 2017;13(10):e1006944. doi: 10.1371/journal.pgen.1006944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1006944</ArticleId><ArticleId IdType="pmc">PMC5628782</ArticleId><ArticleId IdType="pubmed">28981501</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleiman PM, Grant SF. Mendelian randomization in the era of genomewide association studies. Clin Chem. 2010;56(5):723&#x2013;728. doi: 10.1373/clinchem.2009.141564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2009.141564</ArticleId><ArticleId IdType="pubmed">20224045</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Timofeeva M, Farrington SM, Vaughan-Shaw P, Svinti V, Walker M, Zgaga L, Meng X, Li X, Spiliopoulou A, et al. Exploring causality in the association between circulating 25-hydroxyvitamin D and colorectal cancer risk: a large Mendelian randomisation study. BMC Med. 2018;16(1):142. doi: 10.1186/s12916-018-1119-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-018-1119-2</ArticleId><ArticleId IdType="pmc">PMC6090711</ArticleId><ArticleId IdType="pubmed">30103784</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao JV, Schooling CM. Effect of linoleic acid on ischemic heart disease and its risk factors: a Mendelian randomization study. BMC Med. 2019;17(1):61. doi: 10.1186/s12916-019-1293-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-019-1293-x</ArticleId><ArticleId IdType="pmc">PMC6417131</ArticleId><ArticleId IdType="pubmed">30866921</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng P, Zhou X. Causal association between birth weight and adult diseases: evidence from a Mendelian randomization analysis. Front Genet. 2019;10:618. doi: 10.3389/fgene.2019.00618.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2019.00618</ArticleId><ArticleId IdType="pmc">PMC6635582</ArticleId><ArticleId IdType="pubmed">31354785</ArticleId></ArticleIdList></Reference><Reference><Citation>Au Yeung SL, Luo S, Schooling CM. The impact of glycated hemoglobin (HbA1c) on cardiovascular disease risk: a Mendelian randomization study using UK Biobank. Diabetes Care. 2018;41(9):1991. doi: 10.2337/dc18-0289.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc18-0289</ArticleId><ArticleId IdType="pubmed">29950300</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo S, Au Yeung SL, Zhao JV, Burgess S, Schooling CM. Association of genetically predicted testosterone with thromboembolism, heart failure, and myocardial infarction: Mendelian randomisation study in UK Biobank. Br Med J. 2019;364:l476. doi: 10.1136/bmj.l476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l476</ArticleId><ArticleId IdType="pmc">PMC6402044</ArticleId><ArticleId IdType="pubmed">30842065</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;n MA, Robins JM. Instruments for causal inference: an epidemiologist&#x2019;s dream? Epidemiology. 2006;17(4):360&#x2013;372. doi: 10.1097/01.ede.0000222409.00878.37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ede.0000222409.00878.37</ArticleId><ArticleId IdType="pubmed">16755261</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue A, Wu Y, Zhu Z, Zhang F, Kemper KE, Zheng Z, Yengo L, Lloyd-Jones LR, Sidorenko J, Wu Y, et al. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun. 2018;9(1):2941. doi: 10.1038/s41467-018-04951-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04951-w</ArticleId><ArticleId IdType="pmc">PMC6063971</ArticleId><ArticleId IdType="pubmed">30054458</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133&#x2013;1163. doi: 10.1002/sim.3034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.3034</ArticleId><ArticleId IdType="pubmed">17886233</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehan NA, Didelez V, Burton PR, Tobin MD. Mendelian randomisation and causal inference in observational epidemiology. PLoS Med. 2008;5(8):e177. doi: 10.1371/journal.pmed.0050177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0050177</ArticleId><ArticleId IdType="pmc">PMC2522255</ArticleId><ArticleId IdType="pubmed">18752343</ArticleId></ArticleIdList></Reference><Reference><Citation>Au Yeung SL, Lam HSHS, Schooling CM. Vascular endothelial growth factor and ischemic heart disease risk: a Mendelian randomization study. J Am Heart Assoc. 2017;6(8):e005619. doi: 10.1161/JAHA.117.005619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.117.005619</ArticleId><ArticleId IdType="pmc">PMC5586422</ArticleId><ArticleId IdType="pubmed">28765276</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris AP, Voight BF, Teslovich TM, Ferreira T, Segr&#xe8; AV, Steinthorsdottir V, Strawbridge RJ, Khan H, Grallert H, Mahajan A, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44(9):981&#x2013;990. doi: 10.1038/ng.2383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2383</ArticleId><ArticleId IdType="pmc">PMC3442244</ArticleId><ArticleId IdType="pubmed">22885922</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda Y, Kvale MN, Hoffmann TJ, Hesselson SE, Ranatunga D, Tang H, Sabatti C, Croen LA, Dispensa BP, Henderson M. Characterizing race/ethnicity and genetic ancestry for 100,000 subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) cohort. Genetics. 2015;200(4):1285&#x2013;1295. doi: 10.1534/genetics.115.178616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.115.178616</ArticleId><ArticleId IdType="pmc">PMC4574246</ArticleId><ArticleId IdType="pubmed">26092716</ArticleId></ArticleIdList></Reference><Reference><Citation>Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, Motyer A, Vukcevic D, Delaneau O, O&#x2019;Connell J, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562(7726):203&#x2013;209. doi: 10.1038/s41586-018-0579-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0579-z</ArticleId><ArticleId IdType="pmc">PMC6786975</ArticleId><ArticleId IdType="pubmed">30305743</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng P, Zhou X. Causal effects of blood lipids on amyotrophic lateral sclerosis: a Mendelian randomization study. Hum Mol Genet. 2019;28(4):688&#x2013;697. doi: 10.1093/hmg/ddy384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy384</ArticleId><ArticleId IdType="pmc">PMC6360326</ArticleId><ArticleId IdType="pubmed">30445611</ArticleId></ArticleIdList></Reference><Reference><Citation>Cragg JG, Donald SG. Testing identifiability and specification in instrumental variable models. Econometric Theory. 1993;9(2):222&#x2013;240. doi: 10.1017/S0266466600007519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0266466600007519</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Small DS, Thompson SG. A review of instrumental variable estimators for Mendelian randomization. Stat Methods Med Res. 2017;26(5):2333&#x2013;2355. doi: 10.1177/0962280215597579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280215597579</ArticleId><ArticleId IdType="pmc">PMC5642006</ArticleId><ArticleId IdType="pubmed">26282889</ArticleId></ArticleIdList></Reference><Reference><Citation>Noyce AJ, Kia DA, Hemani G, Nicolas A, Price TR, De Pablo-Fernandez E, Haycock PC, Lewis PA, Foltynie T, Davey Smith G, et al. Estimating the causal influence of body mass index on risk of Parkinson disease: a Mendelian randomisation study. PLoS Med. 2017;14(6):e1002314. doi: 10.1371/journal.pmed.1002314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002314</ArticleId><ArticleId IdType="pmc">PMC5469450</ArticleId><ArticleId IdType="pubmed">28609445</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97(6):1268&#x2013;1283.e1266. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Lipids Genetics C. Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, Ganna A, Chen J, Buchkovich ML, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45(11):1274&#x2013;1283. doi: 10.1038/ng.2797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2797</ArticleId><ArticleId IdType="pmc">PMC3838666</ArticleId><ArticleId IdType="pubmed">24097068</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanai M, Akiyama M, Takahashi A, Matoba N, Momozawa Y, Ikeda M, Iwata N, Ikegawa S, Hirata M, Matsuda K, et al. Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat Genet. 2018;50(3):390&#x2013;400. doi: 10.1038/s41588-018-0047-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0047-6</ArticleId><ArticleId IdType="pubmed">29403010</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandres-Ciga S, Noyce AJ, Hemani G, Nicolas A, Calvo A, Mora G, The IC. The International ALSGC. Tienari PJ, Stone DJ, et al. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann Neurol. 2019;85(4):470&#x2013;481. doi: 10.1002/ana.25431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25431</ArticleId><ArticleId IdType="pmc">PMC6450729</ArticleId><ArticleId IdType="pubmed">30723964</ArticleId></ArticleIdList></Reference><Reference><Citation>Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009;5:150&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pubmed">19229235</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotta LA, Sharp SJ, Burgess S, Perry JRB, Stewart ID, Willems SM, Luan JA, Ardanaz E, Arriola L, Balkau B, et al. Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis. JAMA. 2016;316(13):1383&#x2013;1391. doi: 10.1001/jama.2016.14568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.14568</ArticleId><ArticleId IdType="pmc">PMC5386134</ArticleId><ArticleId IdType="pubmed">27701660</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung CHC, Au Yeung SL, Fong SSM, Schooling CM. Lean mass, grip strength and risk of type 2 diabetes: a bi-directional Mendelian randomisation study. Diabetologia. 2019;62(5):789&#x2013;799. doi: 10.1007/s00125-019-4826-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-019-4826-0</ArticleId><ArticleId IdType="pubmed">30798333</ArticleId></ArticleIdList></Reference><Reference><Citation>Censin JC, Nowak C, Cooper N, Bergsten P, Todd JA, Fall T. Childhood adiposity and risk of type 1 diabetes: a Mendelian randomization study. PLoS Med. 2017;14(8):e1002362. doi: 10.1371/journal.pmed.1002362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002362</ArticleId><ArticleId IdType="pmc">PMC5538636</ArticleId><ArticleId IdType="pubmed">28763444</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard SD, Mukherjee S, Sharp SJ, Proitsi P, Lotta LA, Day F, Perry JRB, Boehme KL, Walter S, Kauwe JS, et al. Associations between potentially modifiable risk factors and Alzheimer disease: a Mendelian randomization study. PLoS Med. 2015;12(6):e1001841. doi: 10.1371/journal.pmed.1001841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001841</ArticleId><ArticleId IdType="pmc">PMC4469461</ArticleId><ArticleId IdType="pubmed">26079503</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan VY, Yarmolinsky J, Lawlor DA, Timpson NJ. Letter regarding article, &#x201c;Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis&#x201d;. Int J Epidemiol. 2019; [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6659363</ArticleId><ArticleId IdType="pubmed">30859189</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes MV, Ala-Korpela M, Smith GD. Mendelian randomization in cardiometabolic disease: challenges in evaluating causality. Nat Rev Cardiol. 2017;14(10):577&#x2013;590. doi: 10.1038/nrcardio.2017.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2017.78</ArticleId><ArticleId IdType="pmc">PMC5600813</ArticleId><ArticleId IdType="pubmed">28569269</ArticleId></ArticleIdList></Reference><Reference><Citation>Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, Powell C, Vedantam S, Buchkovich ML, Yang J. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197&#x2013;206. doi: 10.1038/nature14177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14177</ArticleId><ArticleId IdType="pmc">PMC4382211</ArticleId><ArticleId IdType="pubmed">25673413</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott RA, Lagou V, Welch RP, Wheeler E, Montasser ME, Luan JA, Magi R, Strawbridge RJ, Rehnberg E, Gustafsson S, et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet. 2012;44(9):991&#x2013;1005. doi: 10.1038/ng.2385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2385</ArticleId><ArticleId IdType="pmc">PMC3433394</ArticleId><ArticleId IdType="pubmed">22885924</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler E, Leong A, Liu C-T, Hivert M-F, Strawbridge RJ, Podmore C, Li M, Yao J, Sim X, Hong J, et al. Impact of common genetic determinants of hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: a transethnic genome-wide meta-analysis. PLoS Med. 2017;14(9):e1002383. doi: 10.1371/journal.pmed.1002383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002383</ArticleId><ArticleId IdType="pmc">PMC5595282</ArticleId><ArticleId IdType="pubmed">28898252</ArticleId></ArticleIdList></Reference><Reference><Citation>Benyamin B, He J, Zhao Q, Gratten J, Garton F, Leo PJ, Liu Z, Mangelsdorf M, Al-Chalabi A, Anderson L. Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis. Nat Commun. 2017;8(1):611. doi: 10.1038/s41467-017-00471-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00471-1</ArticleId><ArticleId IdType="pmc">PMC5606989</ArticleId><ArticleId IdType="pubmed">28931804</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki K, Akiyama M, Ishigaki K, Kanai M, Hosoe J, Shojima N, Hozawa A, Kadota A, Kuriki K, Naito M, et al. Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population. Nat Genet. 2019;51(3):379&#x2013;386. doi: 10.1038/s41588-018-0332-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0332-4</ArticleId><ArticleId IdType="pubmed">30718926</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim H, Chasman DI, Smith JD, Mora S, Ridker PM, Nickerson DA, Krauss RM, Stephens M. A multivariate genome-wide association analysis of 10 LDL subfractions, and their response to statin treatment, in 1868 Caucasians. PLoS One. 2015;10(4):e0120758. doi: 10.1371/journal.pone.0120758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0120758</ArticleId><ArticleId IdType="pmc">PMC4405269</ArticleId><ArticleId IdType="pubmed">25898129</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985&#x2013;1998. doi: 10.1093/ije/dyx102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyx102</ArticleId><ArticleId IdType="pmc">PMC5837715</ArticleId><ArticleId IdType="pubmed">29040600</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol. 2016;45(6):1961&#x2013;1974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5446088</ArticleId><ArticleId IdType="pubmed">27616674</ArticleId></ArticleIdList></Reference><Reference><Citation>Yavorska OO, Burgess S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol. 2017;46(6):1734&#x2013;1739. doi: 10.1093/ije/dyx034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyx034</ArticleId><ArticleId IdType="pmc">PMC5510723</ArticleId><ArticleId IdType="pubmed">28398548</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693&#x2013;698. doi: 10.1038/s41588-018-0099-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0099-7</ArticleId><ArticleId IdType="pmc">PMC6083837</ArticleId><ArticleId IdType="pubmed">29686387</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304&#x2013;314. doi: 10.1002/gepi.21965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.21965</ArticleId><ArticleId IdType="pmc">PMC4849733</ArticleId><ArticleId IdType="pubmed">27061298</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377&#x2013;389. doi: 10.1007/s10654-017-0255-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-017-0255-x</ArticleId><ArticleId IdType="pmc">PMC5506233</ArticleId><ArticleId IdType="pubmed">28527048</ArticleId></ArticleIdList></Reference><Reference><Citation>Staley JR, Blackshaw J, Kamat MA, Ellis S, Surendran P, Sun BB, Paul DS, Freitag D, Burgess S, Danesh J. PhenoScanner: a database of human genotype&#x2013;phenotype associations. Bioinformatics. 2016;32(20):3207&#x2013;3209. doi: 10.1093/bioinformatics/btw373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw373</ArticleId><ArticleId IdType="pmc">PMC5048068</ArticleId><ArticleId IdType="pubmed">27318201</ArticleId></ArticleIdList></Reference><Reference><Citation>Solovieff N, Cotsapas C, Lee PH, Purcell SM, Smoller JW. Pleiotropy in complex traits: challenges and strategies. Nat Rev Genet. 2013;14(7):483&#x2013;495. doi: 10.1038/nrg3461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3461</ArticleId><ArticleId IdType="pmc">PMC4104202</ArticleId><ArticleId IdType="pubmed">23752797</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulik-Sullivan B, Finucane HK, Anttila V, Gusev A, Day FR, Loh P-R, ReproGen C. Psychiatric Genomics C. Genetic Consortium for Anorexia Nervosa of the Wellcome Trust Case Control C. Duncan L, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet. 2015;47(11):1236&#x2013;1241. doi: 10.1038/ng.3406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3406</ArticleId><ArticleId IdType="pmc">PMC4797329</ArticleId><ArticleId IdType="pubmed">26414676</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid A, Abid A, Schulz PE. Diabetes mellitus and amyotrophic lateral sclerosis: time to bridge the gap between the bench and the bedside. Eur J Neurol. 2018;25(1):3&#x2013;4. doi: 10.1111/ene.13481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13481</ArticleId><ArticleId IdType="pubmed">29044904</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, White LA. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41(2):118&#x2013;130. doi: 10.1159/000351153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu MS, Cui LY, Fan DS, Chinese ALSA. Age at onset of amyotrophic lateral sclerosis in China. Acta Neurol Scand. 2014;129(3):163&#x2013;167. doi: 10.1111/ane.12157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12157</ArticleId><ArticleId IdType="pubmed">23819875</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ, Cirulli ET, Lasseigne BN, Petrovski S. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17(1):17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>He J, Tang L, Benyamin B, Shah S, Hemani G, Liu R. C9orf72 hexanucleotide repeat expansions in Chinese sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2015;36(9):2660.e1&#x2013;2660.e8. doi: 10.1016/j.neurobiolaging.2015.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.06.002</ArticleId><ArticleId IdType="pubmed">26142124</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F, Aken BL, Barrell D, Zadissa A, Searle S, et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 2012;22(9):1760&#x2013;1774. doi: 10.1101/gr.135350.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.135350.111</ArticleId><ArticleId IdType="pmc">PMC3431492</ArticleId><ArticleId IdType="pubmed">22955987</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogaki K, Li Y, Atsuta N, Tomiyama H, Funayama M, Watanabe H, Nakamura R, Yoshino H, Yato S, Tamura A, et al. Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis. Neurobiol Aging. 2012;33(10):2527.e2511&#x2013;2527.e2516. doi: 10.1016/j.neurobiolaging.2012.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.05.011</ArticleId><ArticleId IdType="pubmed">22727276</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Lin Z, Chen X, Cao B, Wei Q, Ou R, Zhao B, Song W, Wu Y, Shang H-F. Large C9orf72 repeat expansions are seen in Chinese patients with sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2016;38:217.e215&#x2013;217.e222. doi: 10.1016/j.neurobiolaging.2015.10.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.10.021</ArticleId><ArticleId IdType="pubmed">26725464</ArticleId></ArticleIdList></Reference><Reference><Citation>Brion M-JA, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42(5):1497&#x2013;1501. doi: 10.1093/ije/dyt179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyt179</ArticleId><ArticleId IdType="pmc">PMC3807619</ArticleId><ArticleId IdType="pubmed">24159078</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y-W, Hsieh T-F, Li C-I, Liu C-S, Lin W-Y, Chiang J-H, Li T-C, Lin C-C. Increased risk of Parkinson disease with diabetes mellitus in a population-based study. Medicine (Baltimore) 2017;96(3):e5921. doi: 10.1097/MD.0000000000005921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000005921</ArticleId><ArticleId IdType="pmc">PMC5279101</ArticleId><ArticleId IdType="pubmed">28099356</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J. Type 2 diabetes and the risk of Parkinson&#x2019;s disease. Diabetes Care. 2007;30(4):842&#x2013;847. doi: 10.2337/dc06-2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc06-2011</ArticleId><ArticleId IdType="pubmed">17251276</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson SC, Traylor M, Malik R, Dichgans M, Burgess S, Markus HS. Modifiable pathways in Alzheimer&#x2019;s disease: Mendelian randomisation analysis. BMJ. 2017;359:j5375. doi: 10.1136/bmj.j5375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j5375</ArticleId><ArticleId IdType="pmc">PMC5717765</ArticleId><ArticleId IdType="pubmed">29212772</ArticleId></ArticleIdList></Reference><Reference><Citation>Collaborators TGO. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13&#x2013;27. doi: 10.1056/NEJMoa1614362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1614362</ArticleId><ArticleId IdType="pmc">PMC5477817</ArticleId><ArticleId IdType="pubmed">28604169</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, Couratier P. Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol. 2009;256(8):1236&#x2013;1242. doi: 10.1007/s00415-009-5100-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5100-z</ArticleId><ArticleId IdType="pubmed">19306035</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn FJ, Ioannides ZA, van Eijk RPA, Heggie S, Thorpe KA, Ceslis A, Heshmat S, Henders AK, Wray NR, van den Berg LH, et al. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J Neurol Neurosurg Psychiatry. 2018;89(10):1016&#x2013;1023. doi: 10.1136/jnnp-2017-317887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317887</ArticleId><ArticleId IdType="pmc">PMC6166607</ArticleId><ArticleId IdType="pubmed">29706605</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills A-M, Hubbard J, Macklin EA, Glass J, Tandan R, Simpson EP, Brooks B, Gelinas D, Mitsumoto H, Mozaffar T, et al. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet. 2014;383(9934):2065&#x2013;2072. doi: 10.1016/S0140-6736(14)60222-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60222-1</ArticleId><ArticleId IdType="pmc">PMC4176708</ArticleId><ArticleId IdType="pubmed">24582471</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson MP, Cutler RG, Camandola S. Energy intake and amyotrophic lateral sclerosis. NeuroMolecular Med. 2007;9(1):17&#x2013;20. doi: 10.1385/NMM:9:1:17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/NMM:9:1:17</ArticleId><ArticleId IdType="pubmed">17114821</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellogg J, Bottman L, Arra EJ, Selkirk SM, Kozlowski F. Nutrition management methods effective in increasing weight, survival time and functional status in ALS patients: a systematic review. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(1&#x2013;2):7&#x2013;11. doi: 10.1080/21678421.2017.1360355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1360355</ArticleId><ArticleId IdType="pubmed">28799809</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu H, Deng H, Hu Z. Plasma progranulin concentrations are increased in patients with type 2 diabetes and obesity and correlated with insulin resistance. Mediat Inflamm. 2013;2013:360190. doi: 10.1155/2013/360190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/360190</ArticleId><ArticleId IdType="pmc">PMC3588183</ArticleId><ArticleId IdType="pubmed">23476101</ArticleId></ArticleIdList></Reference><Reference><Citation>Laird AS, Van Hoecke A, De Muynck L, Timmers M, Van Den Bosch L, Van Damme P, Robberecht W. Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathy. PLoS One. 2010;5(10):e13368. doi: 10.1371/journal.pone.0013368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013368</ArticleId><ArticleId IdType="pmc">PMC2954192</ArticleId><ArticleId IdType="pubmed">20967127</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa Fatima, Lu Shan, Yu Haiyang, Chen Cong, Melamed Ze&#x2019;ev, Guo Lin, Shorter James, Da Cruz Sandrine, Cleveland Don W. Cytoplasmic TDP-43 De-mixing Independent of Stress Granules Drives Inhibition of Nuclear Import, Loss of Nuclear TDP-43, and Cell Death. Neuron. 2019;102(2):339-357.e7. doi: 10.1016/j.neuron.2019.02.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.02.038</ArticleId><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann Jacob R., Gleixner Amanda M., Mauna Jocelyn C., Gomes Edward, DeChellis-Marks Michael R., Needham Patrick G., Copley Katie E., Hurtle Bryan, Portz Bede, Pyles Noah J., Guo Lin, Calder Christopher B., Wills Zachary P., Pandey Udai B., Kofler Julia K., Brodsky Jeffrey L., Thathiah Amantha, Shorter James, Donnelly Christopher J. RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43. Neuron. 2019;102(2):321-338.e8. doi: 10.1016/j.neuron.2019.01.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.01.048</ArticleId><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Davey Smith G, Ebrahim S. &#x2018;Mendelian randomization&#x2019;: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1&#x2013;22. doi: 10.1093/ije/dyg070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyg070</ArticleId><ArticleId IdType="pubmed">12689998</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Q, Zheng Z, Guo X, Ou R, Chen X, Huang R, Yang J, Shang H. Association between depression and survival in Chinese amyotrophic lateral sclerosis patients. Neurol Sci. 2016;37(4):557&#x2013;563. doi: 10.1007/s10072-015-2472-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-015-2472-y</ArticleId><ArticleId IdType="pubmed">26758858</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe H, Atsuta N, Nakamura R, Hirakawa A, Watanabe H, Ito M, Senda J, Katsuno M, Izumi Y, Morita M, Tomiyama H, et al. Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(3&#x2013;4):230&#x2013;236. doi: 10.3109/21678421.2014.990036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.990036</ArticleId><ArticleId IdType="pubmed">25548957</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology. 2009;73(10):805&#x2013;811. doi: 10.1212/WNL.0b013e3181b6bbbd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181b6bbbd</ArticleId><ArticleId IdType="pmc">PMC2739608</ArticleId><ArticleId IdType="pubmed">19738176</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>